Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. VVCIF

Healthcare Drug Manufacturers - Specialty & Generic
VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

VIVO Cannabis Inc. > Vivo doing all the right things...but clearly a 2021 story
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(105)
•••
Comment by Schaffhausenon Oct 05, 2020 7:24am
183 Views
Post# 31665667

RE:Vivo doing all the right things...but clearly a 2021 story

RE:Vivo doing all the right things...but clearly a 2021 story
I'm not excited by eu gmp licensing. Vivo is building its presence in Germany without supplying feedstocks from Canada; thats what Linneo deal is for. Any fledgling Germany sales won't have high margin but who cares, that is not the primary goal as they work to develop the market and build branding. When EU GMP comes to Napanee likely in 2021 that will help in 2022 and beyond if Vivo has success in building up German market in the meantime. The real prize for Vivo is simple...continue on their growth path...continue with the sixth consecutive quarter of revenue growth...continue to lead the concentrates markets...continue to control costs...continue to lead novel recreational product development...continue to use data analytics to define pharmaceutical products and marketing...continue to market high margin brands. Cheers, Schaff
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities